DCM Shriram has approved a significant capital investment plan for its wholly-owned subsidiary, Hindusthan Specialty Chemicals Ltd (HSCL). The company plans to invest Rs 101 crore to enhance HSCL’s Formulated Resins (FR) capacity by 36,000 tonnes per annum (TPA), increasing the total FR capacity to 50,000 TPA. This investment is part of the company’s strategy to bolster its Advanced Materials portfolio within its Chemicals business.
In addition to this investment, DCM Shriram‘s board has authorised financial assistance of up to Rs 100 crore for HSCL. This assistance will be provided through a combination of equity and debt, further supporting the subsidiary’s expansion initiatives.
The board meeting, held on 12th and 13th May 2026, also saw the approval of the audited financial results for the quarter and financial year ending 31st March 2026. The company reported a final dividend recommendation of 200%, equivalent to Rs 4 per equity share with a face value of Rs 2 each. If approved by shareholders at the upcoming 37th Annual General Meeting (AGM), the total dividend for the financial year 2025-26 will amount to 560%, or Rs 11.20 per equity share, including interim dividends declared earlier.
The board has also proposed the cancellation of 39,00,000 forfeited equity shares, which were initially forfeited in January 2005 due to non-payment of call money. The cancellation is subject to shareholder approval.
The 37th AGM is scheduled for 18th August 2026, where these proposals will be presented for shareholder approval.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).